This small-cap stock is expected to take off
Terns Pharma is due to release data from an early-stage trial of an obesity treatment in pill form in the second half. Positive data would send the stock…
Source: biztoc.com
📰 Terns Pharma News
Terns Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Terns Pharma. Real-time updates on events, politics, business and more.
Terns Pharma Stock (NASDAQ:TERN), Quotes and News Summary
<a href="https://public.com/stocks/TERN">Terns Pharma Stock (NASDAQ: TERN)</a> stock price, news, charts, stock research, profile.
Source: benzinga.com
Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes
This study examines the efficacy and safety of tirzepatide vs insulin lispro adjunctive therapy to insulin glargine among those receiving basal insulin with ina
Eteläuomen Läi United States Czech Republic Eli Lilly Julio Rosenstock European Association For The Study Of Diabetes
Source: jamanetwork.com
Tirzepatide With Insulin Glargine Improves Type 2 Diabetes
Adding tirzepatide to insulin glargine leads to greater improvements in A1c, body weight, and less hypoglycemia compared with prandial insulin lispro show data simultaneously published in JAMA.
United States Juan Pablo Frias Eli Lilly Los Angeles Novo Nordisk European Association For The Study Of Diabetes
Source: medscape.com
Benzinga's Top Ratings Upgrades, Downgrades For June 22, 2023 - Agree Realty (NYSE:ADC), Zura Bio (NASDAQ:ZURA), Despegar.com (NYSE:DESP), Enphase Energy (NASDAQ:ENPH), TripAdvisor (NASDAQ:TRIP), Toro (NYSE:TTC), Humacyte (NASDAQ:HUMA), Taboola.com (NASDAQ:TBLA), Bunge (NYSE:BG), Expedia Group (NASDAQ:EXPE), Eneti (NYSE:NETI), trivago (NASDAQ:TRVG), Archer-Daniels Midland (NYSE:ADM), Terns Pharma (NASDAQ:TERN), DiaMedica Therapeutics (NASDAQ:DMAC), Kellogg (NYSE:K), PPL (NYSE:PPL), Pembina Pipeline (NYSE:PBA), Iridium Comms (NASDAQ:IRDM), TScan Therapeutics (NASDAQ:TCRX), FingerMotion (NASDAQ:FNGR), Outbrain (NASDAQ:OB), Tesla (NASDAQ:TSLA), DigitalOcean Holdings (NYSE:DOCN), Alcoa (NYSE:AA), Chemours (NYSE:CC), Celanese (NYSE:CE), Dow (NYSE:DOW), Grab Hldgs (NASDAQ:GRAB), AES (NYSE:AES), Andersons (NASDAQ:ANDE), Everest Re Group (NYSE:RE), Caterpillar (NYSE:CAT), PagSeguro Digital (NYSE:PAGS), XP (NASDAQ:XP), Equinix (NASDAQ:EQIX), Xcel Energy (NASDAQ:XEL), Mercury Sys (NASDAQ:MRCY)
Source: benzinga.com
7 Biotech Stocks With Key Catalysts in March
These seven stocks have some key catalysts lined up for March with the potential to move their price actions in big ways.
United States Robert Califf Dana Pizzuti Bristol Myers Squibb Central Nervous System Drugs Advisory Committee Drug Administration
Source: investorplace.com